Tahseen I. Al-Saleem, MD

Tahseen Al-Saleem, MD
​​
This physician is not currently rated. Why?

Why is this doctor not rated?

Close

To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles. Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive evaluation and ratings from patients.

More about patient ratings
Request an Appointment

Clinical Locations

Professor Emeritus, Department of Pathology

Treatment Philosophy

I chose to work at Fox Chase because I like oncologic (cancer) pathology and love the institutional environment. The best part of my job is interaction with other colleagues: pathologists, clinicians and researchers. That is why I've stayed at Fox Chase for more than 15 years.

Advances in medicine have improved the way in which we understand cancer and deal with it. An accurate, comprehensive diagnosis means everything to the patients who come here as well as the physicians who plan their treatment. As a pathologist, I enjoy working with the other physicians because they count on our accuracy in order to get best results in cancer management and for future progress in the field.

Educational Background

St. Christopher's Hospital for Children, Philadelphia - See more at: http://www.foxchase.org/physicians/team/pathology/al-saleem.html#sthash.zbmDxCBc.dpuf
  • Fellow, St. Christopher's Hospital for Children, Philadelphia, PA
  • Resident, Pathology, Temple University Hospital, Philadelphia, PA
  • MB, ChB, Medicine, University of Baghdad School of Medicine, Iraq, 1961

Certifications

  • American Board of Pathology
  • Anatomic and Clinical Pathology
  • Hematopathology

Memberships

  • College of American Pathologists
  • Clinical Cytometry Society
  • American Society of Hematology

Honors & Awards

  • Lifetime Achievement Award, Iraqi Society of United Kingdom, 2016
  • Lifetime Achievement Award: Iraqi Medical Sciences Association , 2014
  • Award of excellence in Pathology: Mandaean Medical Professionals Association 5th Convention, 2014
  • Best Medical Oncology Teacher, Fox Chase Cancer Center, 2005
  • Best Professor's Award, University of Baghdad, 1985

Research Interests

  • Contribution to the development of animal models for lymphoma
  • Investigation and description of new or unusual hemopoietic malignancies

Selected Publications

Saroha S, Uzzo RG, Plimack ER, Ruth K, Al-Saleem T.  Lymphopenia is an Independent Predictor of inferior outcome in clear cell renal carcinoma. J. Urol. 2013 Feb; 189(2): 454-61. doi: 10.1016/j.juro.2012. 09. 166. Epub 2012 Oct 4. PubMed

Post-radiotherapy prostate biopsies reveal heightened apex positive relative to other prostate regions sampled. Huang KT, Stoyanova R, Waler G, Sandler K, Studenski MT, Dogan N. Al-Saleem T,Buyyounouski MD, Horwotz EM, Pollack A. Radiother Onncol. 2015 Apr:115(1):101-6 doi: 10.1016/j.radonc.2015.03.006. Epub 2015 May 8. PubMed

PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection. Alexander W. MacFarlane IV1, Mowafaq Jillab14, Elizabeth R. Plimack, Gary R. Hudes, Robert G. Uzzo, Samuel Litwin, Essel Dulaimi, Tahseen Al-Saleem, and Kerry S. Campbell PubMed

MicroRNA expression signatures of stage, grade, and progression in clear cell RCC. Gowrishankar B, Ibragimova I, Zhou Y, Slifker MJ, Devarajan K, Al-Saleem T, Uzzo RG, Cairns P.Cancer Biol Ther. 2014 Mar 1;15(3):329-41. doi: 10.4161/cbt.27314. Epub 2013 Dec PubMed

Renal cell carcinoma metastasis to a contralateral oncocytoma in a patient presenting with bilateral synchronous renal tumors. Mehrazin R, Wong YN, Wu H, Al-Saleem T, Smaldone M. Clin Genitourin Cancer. 2013 Dec;11(4):e27-9. doi: 10.1016/j.clgc.2013.06.001. Epub 2013 Sep

A. J Urol. Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass:   implications for  treating patients following renal biopsy. Ginzburg S, Uzzo R, Al-Saleem T, Dulaimi E, Walton J, Corcoran A, Plimack E, Mehrazin R, Tomaszewski J, Viterbo R, Chen DY, Greenberg R, Smaldone M, Kutikov 2014 Feb;191(2):296-300. doi: 10.1016/j.juro.2013.07.059. Epub 2013 Jul 27. PubMed

Gleason scoring at a comprehensive cancer center: what's the difference? Townsend NC, Ruth K, Al-Saleem T, Horwitz EM, Sobczak M, Uzzo RG, Viterbo R, Buyyounouski MK. PubMed

Germline Mutations in Mtap Cooperate with Myc to Accelerate Tumorigenesis in Mice. Kadariya Y, Tang B, Wang L, Al-Saleem T, Hayakawa K, Slifker MJ, Kruger WD. PLoS One. 2013 Jun 26;8(6):e67635. Print 2013. PubMed

Is there a benefit to frozen section analysis at the time of partial nephrectomy? Sterious SN, Simhan J, Smaldone MC, Tsai KJ, Canter D, Wameedh E, Li T, Helstrom J, Viterbo R, Chen DY, Greenberg RE, Kutikov A, Al-Saleem T, Uzzo RG. Can J Urol. 2013 Jun;20(3):6778-84. PubMed

Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma. Mehrazin R, et al. Urol Oncol. 2015. PubMed

Gleason Scoring, Updates of the Updates Journal of cancer prevention and research, Editorial , May 2016 

Low Level of Blood CD4+ T Cells Is an Independent Predictor of Inferior Progression-free   Survival in Diffuse Large B-cell Lymphoma. Judd J, Dulaimi E, Li T, Millenson MM, Borghaei H, Smith MR, Al-Saleem T. Clin Lymphoma Myeloma Leuk. 2017 Feb;17(2):83-88. doi: 10.1016/j.clml.2016.11.005. Epub 2016 Nov 30. PubMed

What Is “Cancer” Is There A Need for New Terminologies? Journal of Cancer Prevention and Current Research. Vol 4 Issue 2 2016

 

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...
​​